Further study is needed to determine how much highly methylated ICC defined by the eight-marker panel of the present study coincides with the IDH1/2 mutation-enriched molecular subtype defined by multiplatform analysis. This evidence concerns the gene IDH1 and intrahepatic cholangiocarcinoma.